SCHEMBL5651392

SCHEMBL5651392

CC(C)(C)OC(=O)NN1CCC=C(CNCc2ccc3c(c2)OCCO3)C1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
ALDH1A1 P00352 5/20 0.37
ALKBH5 Q6P6C2 1/20 0.37
FTO Q9C0B1 1/20 0.37
HDAC1 Q13547 1/20 0.36
GALR3 O60755 1/20 0.36
RAB9A P51151 1/20 0.36
BMP1 P13497 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5653634 0.85 KMT2A (0.43) KMT2AMEN1ALDH1A1ALKBH5FTO
SCHEMBL13145848 0.85 KEAP1 (0.41) SMN1; SMN2KMT2AMEN1ALDH1A1ALKBH5
SCHEMBL3686840 0.77 KMT2A (0.41) SMN1; SMN2KMT2AMEN1ALDH1A1ALKBH5
SCHEMBL5651727 0.73 LIPE (0.39) KMT2AMEN1ALDH1A1THRB
SCHEMBL5649603 0.72 LIPE (0.38) KMT2AMEN1ALDH1A1THRB
SCHEMBL5650660 0.70 ALKBH5 (0.43) SMN1; SMN2KMT2AMEN1ALDH1A1ALKBH5
SCHEMBL20605302 0.68 LIPE (0.40) SMN1; SMN2KMT2AMEN1RAB9ATHRB
SCHEMBL30627676 0.68 MAPT (0.57) SMN1; SMN2KMT2AMEN1ALDH1A1RAB9A
SCHEMBL17140257 0.68 KEAP1 (0.51) ALDH1A1RAB9ABMP1MAPTMAPK1
SCHEMBL3565815 0.68 SMN1; SMN2 (0.60) SMN1; SMN2KMT2AMEN1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223776-B2 Compounds with anti-bacterial activity MORPHOCHEM AG (DE) 2007-05-29 US disclosed
US-20060040949-A1 Novel compounds with antibacterial activity MORPHOCHEM AG 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040949-A1 Novel compounds with antibacterial activity MRPL21, Q6ZSR9, MRPL19 SMN1; SMN2 4680/4885KMT2A 4474/4885MEN1 4500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.